4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-25-000141
EVP, Chief Reg. & Quality Off. sold 4,058 shares at $485.49 ($1,970,118)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Tatsis Ourania · EVP, Chief Reg. & Quality Off.
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-04 | Sale : show line 1 in the form 10b5-1 | −4,058 | $485.49 | $1,970,118 | 54,481 | D |
| Open-market sales · 4,058 sh · avg $485.49 · $1,970,118 | ||||||
Loading xslF345X05/wk-form4_1741295323.xml…